期刊
JOURNAL OF CONTROLLED RELEASE
卷 261, 期 -, 页码 246-262出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2017.07.004
关键词
Parkinson's disease; Focused ultrasound; Microbubbles; CNS gene delivery
资金
- Ministry of Science and Technology, Taiwan [105-2221-E-182-022, 105-2221-E-007-055, 105-2119-M-182-001]
- National Tsing Hua University, Taiwan [106N522CE1]
- Chang Gung Memorial Hospital, Taiwan [CIRPD2E0051-53, CMRPD2D0111-13]
Parkinson's disease (PD) is a potent neurodegenerative disease in which a progressive loss of dopaminergic neurons eventually produces a loss of movement control and other symptoms. To date, in addition to pharmacological, non-pharmacological, and neurosurgical therapies, gene delivery has emerged as a potential therapeutic modality for PD. Effective targeted gene delivery is complicated in that gene vectors cannot penetrate the blood-brain barrier (BBB), thus clinical tests must rely on invasive intracerebral gene vector injection. Burst low-pressure focused ultrasound exposure with microbubbles has been demonstrated to noninvasively target and temporally open the BBB, opening new opportunities to transport large molecule substances into the brain for central nervous system (CNS) disease treatment, and raising the potential for noninvasive gene delivery for PD treatment. This paper reviews the underlying mechanism and current progress for focused ultrasound induced CNS gene delivery, and summarizes potential directions for further ultrasound-medicated PD gene therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据